2013-02-20 07:11:45 -

OSLO, NORWAY -- (Marketwire) -- 02/20/13 -- Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that
members of
its senior management team will participate in the following upcoming
investor
conferences:



Citi Global Healthcare Conference 2013



Date: 25-27 February 2013



Participants:



Jeff Albers (President, Algeta US)





Mike Booth (IR)



Panel date & time: Tuesday 25 February, 2013, 10:20am EST



Venue: New York, NY, USA




Credit Suisse Global Healthcare One-on-One Conference



Date: 5-6 March 2013



Participants:



Andrew Kay (President & CEO)



Oystein Soug (CFO)



Mike Booth (IR)



Venue: London, UK




Carnegie Nordic Healthcare Seminar



Date: 12 March 2013



Participants:



Thomas Ramdahl (EVP & CTO)



Renate Birkeli (IR)



Presentation date & time: Tuesday 12 March, 2013, 10:05am CET



Venue: Stockholm, Sweden





Presentations, where applicable, will be available to download at
www.algeta.com : www.algeta.com
following these events.



###



About Algeta



Algeta is a company focused on developing novel targeted therapies for
patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,
based in
Cambridge, MA performing commercial marketing operations in the US. Algeta
is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information
please
visit www.algeta.com : www.algeta.com .



Press release:



hugin.info/134655/R/1679224/548304.pdf : hugin.info/134655/R/1679224/548304.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:



(i) the releases contained herein are protected by copyright and
other applicable laws; and



(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.



Source: Algeta ASA via Thomson Reuters ONE



[HUG#1679224]




For further information, please contact:

Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs
Email Contact : www2.marketwire.com/mw/emailprcntct?id=F2BD86365A4F211C

Media enquiries:
Mark Swallow
+44 207 638 9571

Citigate Dewe Rogerson
Email Contact : www2.marketwire.com/mw/emailprcntct?id=E113B6B588E70BF3

Knut Ekern
+47 22 04 82 00

Gambit Hill & Knowlton
Email Contact : www2.marketwire.com/mw/emailprcntct?id=70B0DBF8D731B7DD

Kari Watson
+1 781 235 3060

MacDougall Biomedical Communications
Email Contact : www2.marketwire.com/mw/emailprcntct?id=9070CB9E36276544

US investor enquiries:
Tricia Swanson
+1 646 378 2953

The Trout Group
Email Contact : www2.marketwire.com/mw/emailprcntct?id=7623DD165070A2E6